Found 13 matching trials
Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma PHASE2 In view of the synergistic effects of rituximab, zanubrutinib, and lenalido...
Show More Location
Henan cancer hospital
Learn More & Join Trial
Zanubrutinib, Obinutuzumab Combined With Lenalidomide (ZGR) for the Treatment of Untreated Follicular Lymphoma PHASE2 This study is planned to prospectively evaluates the efficacy and safety of...
Show More Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences, Tianjin, Tianjin 300020
Learn More & Join Trial
The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma PHASE3 A multicenter, prospective, randomized, open-label, controlled trial to eva...
Show More Location
Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Obinutuzumab, Zanubrutinib, and Lenalidomide in First-line Treatment of Mantle Cell Lymphoma PHASE2 This is a prospective, open-label, single-arm clinical trial evaluating a t...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial PHASE2 :The aim of this study was to analyze the safety and efficacy of Zanubrutin...
Show More Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences
Learn More & Join Trial
The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma. PHASE2 This is a prospective, single-center, open-label clinical study designed to...
Show More Location
First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial Remission PHASE2 This single-arm, prospective clinical study will evaluate the efficacy and ...
Show More Location
Multiple Locations
Learn More & Join Trial
Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL) PHASE2 This is a prospective, multiple-centers, open-label, single-arm clinical st...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL PHASE2 The goal of this phase 2 trial is to test the safety and efficacy of zanubr...
Show More Location
Navy General Hospital
Learn More & Join Trial
Zanubrutinib, Lenalidomide and Rituximab (ZR2) in Elderly Treatment-naive Patients With Diffuse Large B-cell Lymphoma (DLBCL) PHASE2 This is a prospective, single-center, open-label, single-arm clinical study...
Show More Status
Active Not Recruiting
Location
Shanghai Ruijin Hospital
Learn More & Join Trial